Filed: 2/14/2024ACC: 0001104659-24-023815
📋 What this filing means
QIMING U.S. VENTURES MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $109.21M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$109.21M
Total AUM (reported)
17.48M
Total Shares
Allocation by class
COM$109.21M100.0%
Portfolio Concentration
Top 3$89.76M82.2%
4–10$19.45M17.8%
Top 3 weight
82.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 17.48M
Sole
Full voting authority
17.48M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings8
Rows:
ICOSAVAX INC
SOLEShares3.51M
TypeSH
Market value$55.32M
50.66%
Sole
3.51M
Shared
0.00
None
0.00
KORRO BIO INC
SOLEShares368.08K
TypeSH
Market value$17.64M
16.15%
Sole
368.08K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares641.69K
TypeSH
Market value$16.80M
15.38%
Sole
641.69K
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares558.92K
TypeSH
Market value$8.97M
8.21%
Sole
558.92K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares8.52M
TypeSH
Market value$6.72M
6.16%
Sole
8.52M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares686.37K
TypeSH
Market value$1.70M
1.55%
Sole
686.37K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.37M
TypeSH
Market value$1.27M
1.17%
Sole
2.37M
Shared
0.00
None
0.00
KEZAR LIFE SCIENCES INC
SOLEShares828.71K
TypeSH
Market value$785.1K
0.72%
Sole
828.71K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ICOSAVAX INCSOLE | COM | 3.51M | SH | $55.32M 50.66% | 3.51M | 0.00 | 0.00 |
KORRO BIO INCSOLE | COM | 368.08K | SH | $17.64M 16.15% | 368.08K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 641.69K | SH | $16.80M 15.38% | 641.69K | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 558.92K | SH | $8.97M 8.21% | 558.92K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 8.52M | SH | $6.72M 6.16% | 8.52M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 686.37K | SH | $1.70M 1.55% | 686.37K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.37M | SH | $1.27M 1.17% | 2.37M | 0.00 | 0.00 |
KEZAR LIFE SCIENCES INCSOLE | COM | 828.71K | SH | $785.1K 0.72% | 828.71K | 0.00 | 0.00 |